USA Daily Letter
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

USA Daily Letter

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by June 4, 2025
June 4, 2025
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com
0
FacebookTwitterGoogle +Pinterest
previous post
Energy groups celebrate Trump’s latest move to unleash Alaska drilling
next post
Expert speaks out on ‘perfect solution’ to federal hiring issues creating national security concerns

You may also like

Crypto Market Recap: Circle Targets US$7.2 Billion IPO,...

Web Summit 2025: AI Innovation, Investment Shifts and...

In-fill RC Drilling at Kamperman Confirms High-Grade Gold

Ford Government Pushes Bill 5 Through Legislature, Sparking...

Victoria Gold-Silver Exploration Update

Editor’s Picks: Marathon Project Gets Nod, Rio Tinto...

Crypto Market Recap: Strategy Eyes US$1 Billion Capital...

Trump Admin Strips “Safety” from AI Oversight Institute...

Retraction of Lo Herma Scoping Study Statements

US Admin Fast Tracks Laramide Uranium Projects, Meta...

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Trump warns of ‘serious consequences’ if Elon Musk funds Democrats

    • Trump implies government could cut contracts and subsidies to Musk’s companies

    • Musk jokes about reconsidering stance on Big Beautiful Bill after Schiff’s praise

    • Musk deletes explosive posts about Trump and Epstein files

    • House witness flips script on Dem who ambushed him during hearing with unearthed tweet: ‘Iceberg is ahead’

    Categories

    • Business (16)
    • Investing (61)
    • Politics (100)
    • World (47)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: usadailyletter.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 usadailyletter.com | All Rights Reserved


    Back To Top